Mixed
Obesity is metabolically heterogeneous, distinguished by metabolically unhealthy obese (MUHO) phenotypes exhibiting insulin resistance, inflammation, and altered metabolite profiles, versus metabolically healthy obese (MHO) phenotypes.
Do not assume that a high BMI automatically implies poor metabolic health or high disease risk. Metabolically Healthy Obesity (MHO) exists, but Metabolically Unhealthy Obesity (MUHO) carries specific risks like insulin resistance and inflammation. To understand your actual health risk, metabolic markers (like blood sugar, lipids, and inflammation) must be tested, as BMI alone is insufficient.
Within the obese population, clinicians can distinguish between metabolically healthy obese (MHO) and metabolically unhealthy obese (MUHO) subjects. Increased blood pressure, hyperlipidemia, hyperglycemia, hyperuricemia and increased peripheral IR are frequently reported in MUHO subjects.
Why this rating
Based on a systematic review of 33 human studies using metabolomics.
Source
Are we close to defining a metabolomic signature of human obesity? A systematic review of metabolomics studies
Óscar Daniel Rangel-Huerta et al. · Metabolomics · 2019
DOI 10.1007/s11306-019-1553-y
More from this paper
- Elevated levels of branched-chain amino acids (BCAAs) and aromatic amino acids, along with altered lipid profiles (e.g., elevated palmitic acid), serve as consistent metabolomic signatures of obesity and insulin resistance.Good
- Weight loss interventions, including hypocaloric diets and exercise, modulate the metabolomic profile of obese individuals, potentially reversing or altering obesity-related metabolic signatures.Good
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →